Allworth Financial’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79K Sell
2,060
-172
-8% -$4.51K ﹤0.01% 2116
2026
Q1
$47.4K Buy
2,232
+158
+8% +$3.16K ﹤0.01% 2362
2025
Q4
$33.8K Sell
2,074
-210
-9% -$3.17K ﹤0.01% 2460
2025
Q3
$26.7K Buy
2,284
+13
+0.6% +$170 ﹤0.01% 2524
2025
Q2
$26.3K Buy
2,271
+1,364
+150% +$12.4K ﹤0.01% 2346
2025
Q1
$7.54K Buy
907
+829
+1,063% +$10.4K ﹤0.01% 2553
2024
Q4
$1.27K Sell
78
-1,045
-93% -$16.5K ﹤0.01% 3325
2024
Q3
$25.4K Buy
1,123
+155
+16% +$3.2K ﹤0.01% 1759
2024
Q2
$16.2K Buy
968
+480
+98% +$12.6K ﹤0.01% 2007
2024
Q1
$18.3K Sell
488
-11
-2% -$483 ﹤0.01% 1819
2023
Q4
$27.9K Buy
499
+56
+13% +$2.44K ﹤0.01% 1451
2023
Q3
$18.3K Buy
443
+3
+0.7% +$156 ﹤0.01% 1587
2023
Q2
$24.6K Hold
440
﹤0.01% 1415
2023
Q1
$24.5K Sell
440
-24,541
-98% -$1.15M ﹤0.01% 1346
2022
Q4
$1.88M Buy
24,981
+24,966
+166,440% +$816K 0.02% 251
2022
Q3
$0 Buy
15
+6
+67% +$229 ﹤0.01% 3122
2022
Q2
$0 Buy
9
+6
+200% +$311 ﹤0.01% 2826
2022
Q1
$0 Sell
3
-63
-95% -$5.51K ﹤0.01% 2390
2021
Q4
$10K Buy
+66
New +$10.1K ﹤0.01% 1387

Other funds holding TXG

Allworth Financial's TXG Position: Q2 2026 in Review

Allworth Financial reduced its 10x Genomics (TXG) stake by 7.7% in Q2 2026, selling an estimated $4.51K and leaving 2,060 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Allworth Financial first reported a position in TXG in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q4 2022. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Allworth Financial held 2,060 shares of 10x Genomics worth $79K as of Q2 2026.
  • Allworth Financial sold 172 10x Genomics shares in Q2 2026, an estimated $4.51K.
  • 10x Genomics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2116 holding.
  • Allworth Financial first reported a position in 10x Genomics in Q4 2021 and has held it in 19 quarters since.
  • Allworth Financial's 10x Genomics position peaked at $1.88M in Q4 2022.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.